Disposable fascia release embedded needle

Abstract

The utility model discloses a disposable fascia releasing embedded needle, and relates to the technical field of medical instruments. Comprising a conveying part detachably connected with an injector, and the end, away from the injector, of the conveying part is detachably connected with an embedding part used for being embedded in fascia; the conveying part comprises a needle handle, and a needle core is fixedly connected in the needle handle; the embedding part comprises a connecting tube, the end, away from the injector, of the needle handle is detachably connected with the connecting tube, the end, away from the needle handle, of the connecting tube is fixedly connected and communicated with a needle body, and medicine injection holes are symmetrically formed in the outer wall of the end, away from the connecting tube, of the needle body; one end, extending into the needle handle, of the needle core is communicated with the injector through the needle handle; and one end of the needle core extending out of the needle handle penetrates through the connecting tube and extends into the needle body. According to the utility model, fascia release, medicine injection and needle body retention can be effectively carried out, fascia stimulation and acupoint stimulation effects are achieved through retention of the needle body, the effect that one needle has multiple purposes is achieved, multiple times of puncture on fascia are reduced, and damage to blood vessels and nerves is reduced.

Description

Technical Field

[0001] This utility model relates to the field of medical device technology, and in particular to a disposable fascia release implantation needle. Background Technology

[0002] In the field of medical diagnosis and treatment, significant progress has been made in the research of fascia. Fascial lesions can lead to pathological changes such as pain, blood stasis, and tissue adhesions. At the same time, fascia is also a support and reserve system for tissue repair. Stimulating fascia can eliminate pain, improve microcirculation, and promote and activate tissue repair. Fascial lesions and soft tissue lesions such as fasciitis and fascial adhesions are very common and important diseases. In the fields of orthopedics, pain management, and rehabilitation, such as lumbar disc herniation, myofasciitis, arthritis, and muscle weakness after stroke, fascial stimulation and drug injection are often used, including silver needle heat conduction technology, internal heat needle technology, needle knife fascia release, needle fascia release, thread embedding, floating needle, as well as nerve block and acupoint injection, to promote and activate tissue repair.

[0003] Currently, there are various methods and a wide variety of needles available. Although all of them show relatively good results, they suffer from limited application and cannot combine the advantages of their respective treatment techniques to achieve better therapeutic effects. Among them, needle knife technique, floating needle technique, internal heat needle, and silver needle have sharp needle tips, which are easy to puncture, but have poor direct release effect on fascia. On the other hand, the needle-pulling technique can thoroughly release fascia, but it cannot complete drug injection and needle implantation.

[0004] In summary, there is an urgent need for a method that can perform blunt release of the fascia, smoothly administer drug injection, and simultaneously embed the needle within the fascia to achieve fascial and acupoint stimulation. To this end, improvements to the needle body, especially the needle tip, are needed to effectively meet these requirements and achieve better therapeutic effects. Utility Model Content

[0005] The purpose of this invention is to provide a disposable myofascial release implantation needle to solve the problems existing in the prior art.

[0006] To achieve the above objectives, this utility model provides the following solution: This utility model provides a disposable fascia release implantation needle, including a delivery part detachably connected to a syringe, wherein an implantation part for embedding in the fascia is detachably connected to the end of the delivery part away from the syringe; the delivery part includes a needle handle, and a needle core is fixedly connected inside the needle handle; the implantation part includes a connecting tube, wherein the end of the needle handle away from the syringe is detachably connected to the connecting tube, and a needle body is fixedly connected to and communicates with the end of the connecting tube away from the needle handle; symmetrical injection holes are provided on the outer wall of the end of the needle body away from the connecting tube; one end of the needle core extending into the needle handle is connected to the syringe through the needle handle; the other end of the needle core extending out of the needle handle passes through the connecting tube and extends into the needle body.

[0007] Preferably, the needle handle has an interface at one end facing the syringe, and the interface is detachably connected to the syringe.

[0008] Preferably, the interface is tapered, and the smaller end of the interface opening is connected to the needle core.

[0009] Preferably, the end of the needle body furthest from the connecting tube has a blunt tip.

[0010] Preferably, the needle tip at one end of the needle core inserted into the needle body has a transverse cut.

[0011] Preferably, the length of the needle core extending beyond the needle handle is not greater than the length of the needle body.

[0012] Preferably, the end of the needle handle facing the connecting tube is conical.

[0013] Preferably, the needle body and the connecting tube are integrally formed.

[0014] Preferably, the needle body and the connecting tube are made of plastic.

[0015] The present invention discloses the following technical effects:

[0016] This invention, by inserting the needle core into the needle body, effectively maintains a certain strength and elasticity of the needle body, facilitating the needle body to enter the subcutaneous fascia for blunt dissection and release. Simultaneously, by inserting the syringe into the needle handle, the injection port on the needle body allows for drug injection into the fascia and aspiration of blood caused by puncture. After the fascia is released, the needle handle is separated from the needle body, leaving the needle body in the subcutaneous fascia, allowing the needle body to continue stimulating the fascia, activating its activity, and promoting tissue repair.

[0017] This invention achieves fascia and acupoint stimulation through needle placement, realizing the effect of one needle for multiple purposes, reducing the need for multiple punctures of the fascia, and reducing damage to blood vessels and nerves; at the same time, it not only effectively reduces the pain of multiple punctures for patients, but also effectively increases the safety of treatment. Attached Figure Description

[0018] To more clearly illustrate the technical solutions in the embodiments of this utility model or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this utility model. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0019] Figure 1 This is a schematic diagram of the overall structure of this utility model;

[0020] Figure 2 This is a schematic diagram of the conveying section of this utility model;

[0021] Figure 3 This is a schematic cross-sectional view of the needle handle of this utility model;

[0022] Figure 4 This is a schematic diagram of the embedded part structure of this utility model;

[0023] Figure 5 This is a cross-sectional view of the embedded part of this utility model;

[0024] The components are: 1. needle handle; 2. needle core; 3. needle body; 4. connecting tube; 5. blunt tip; 6. injection hole; 7. interface. Detailed Implementation

[0025] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.

[0026] To make the above-mentioned objectives, features and advantages of this utility model more apparent and understandable, the utility model will be further described in detail below with reference to the accompanying drawings and specific embodiments.

[0027] Example 1

[0028] Reference Figures 1-5This utility model discloses a disposable fascia release implantation needle, including a delivery part detachably connected to a syringe, and an implantation part for embedding in the fascia at the end of the delivery part away from the syringe; the delivery part includes a needle handle 1, and a needle core 2 is fixedly connected inside the needle handle 1; the implantation part includes a connecting tube 4, the end of the needle handle 1 away from the syringe is detachably connected to the connecting tube 4, the end of the connecting tube 4 away from the needle handle 1 is fixedly connected to and communicates with a needle body 3, and injection holes 6 are symmetrically opened on the outer wall of the end of the needle body 3 away from the connecting tube 4; one end of the needle core 2 extends into the needle handle 1 and is connected to the syringe through the needle handle 1; the other end of the needle core 2 extends out of the needle handle 1 and passes through the connecting tube 4 and extends into the needle body 3.

[0029] This invention, by inserting the needle core 2 into the needle body 3, enables the needle body 3 to effectively maintain a certain strength and elasticity, facilitating its entry into the subcutaneous fascia for blunt dissection and release. Simultaneously, by inserting the syringe into the needle handle 1, the injection port 6 on the needle body 3 allows for drug injection into the fascia and aspiration of blood caused by puncture. After the fascia is released, the needle handle 1 is separated from the needle body 3, leaving the needle body 3 in the subcutaneous fascia, allowing it to continue stimulating the fascia, activating its activity, and promoting tissue repair.

[0030] This invention achieves fascia and acupoint stimulation through the placement of the needle body 3, realizing the effect of one needle for multiple purposes, reducing the need for multiple punctures of the fascia, and reducing damage to blood vessels and nerves; at the same time, it not only effectively reduces the pain of multiple punctures for patients, but also effectively increases the safety of treatment.

[0031] In a further optimized design, an interface 7 is provided inside the end of the needle handle 1 facing the syringe, and the interface 7 is detachably connected to the syringe. By installing the syringe onto the interface 7, the syringe can effectively inject drugs into the fascia and aspirate blood caused by bleeding during puncture.

[0032] The design was further optimized by incorporating a conical opening for the interface 7, with the smaller opening connected to the needle core 2. This conical shape of the interface 7 allows for a tight and sealed installation of the syringe, effectively improving the seal between the interface 7 and the syringe.

[0033] The design was further optimized by making the end of the needle body 3 furthest from the connecting tube 4 a blunt tip 5. By making the end of the needle body 3 inserted into the fascia a blunt tip 5, the blunt tip 5 can perform blunt dissection and release of the fascia. In addition, the blunt tip 5 can also avoid puncturing blood vessels and damaging nerves, effectively improving the safety of fascia release.

[0034] The design was further optimized so that the needle tip at the end of the needle core 2 inserted into the needle body 3 has a transverse cut. By making the needle tip at the end of the needle core 2 inserted into the needle body 3 a transverse cut, the needle tip of the needle core 2 is effectively prevented from piercing the needle body 3, and damage to blood vessels and nerves is effectively avoided, thus significantly improving safety during use.

[0035] The design was further optimized so that the length of the needle core 2 extending beyond the needle handle 1 is no greater than the length of the needle body 3. This effectively prevents the needle tip of the needle core 2 from piercing the needle body 3 when it extends into the needle body 3.

[0036] In a further optimized design, the end of the needle handle 1 facing the connecting tube 4 is conical. The connecting tube 4 is adapted to the conical shape on the needle handle 1, and the length of the connecting tube 4 is not less than the length of the conical shape on the needle handle 1, so that the connecting tube 4 can be effectively fitted onto the needle handle 1, and the sealing performance at the connection between the connecting tube and the needle handle 1 is effectively improved.

[0037] The design was further optimized, with the needle body 3 and the connecting tube 4 integrally molded. This effectively improved the sealing performance between the needle body 3 and the connecting tube 4.

[0038] The design was further optimized by using plastic materials for both the needle body 3 and the connecting tube 4. This plastic material facilitates the placement of the needle body 3 within the fascia, effectively improving its adaptability to the human body.

[0039] Working process: First, a puncture is performed. During the puncture, local anesthesia is first applied to the puncture site, followed by scalp puncture. After the puncture is completed, the needle body 3 is installed on the needle handle 1, and the connecting tube 4 is tightly connected to the needle handle 1. Then, the needle body 3 is inserted into the subcutaneous fascia through the puncture needle hole at the puncture site. At this time, blunt dissection and release of the fascia can be performed through the blunt tip 5. The blunt tip 5 can effectively avoid puncturing blood vessels and damaging nerves, effectively improving the safety of fascia release. After the fascia release is completed, the syringe is inserted into the interface 7 to recover any bleeding. The blood enters the needle body 3 through the injection port 6, and the blood is aspirated back through the syringe. After the residual blood is cleaned up, a new syringe is replaced to inject drugs or gases such as ozone. Drugs or gases such as ozone can enter the fascia through the injection port 6 to effectively carry out intrafascial anti-inflammatory treatment.

[0040] After the fascia is dissected and released through the needle body 3, the needle core 2 is removed from the needle body 3, while the needle body 3 remains inside the fascia. At the same time, to prevent external contaminants from entering the needle body 3 and causing bacterial growth, the connecting tube 4 is detachably connected to a rubber stopper. The rubber stopper seals the connecting tube 4, effectively preventing external contaminants from entering the needle body 3 and thus effectively preventing infection. At this time, the blunt tip 5 of the needle body 3 can continuously stimulate the fascia and acupoints, effectively achieving the therapeutic effects of existing thread embedding and floating needle techniques.

[0041] Example 2

[0042] The difference between this embodiment and Embodiment 1 is that, in order to facilitate convenient and smooth operation during puncture, the needle handle 1 is a long quadrangular prism with a length of 3cm and a side length of 6mm for the cross-section of the needle handle 1. The long quadrangular prism facilitates a stable grip on the needle handle 1, and the needle body 3 can be effectively inserted into the subcutaneous fascia along the puncture needle hole at the puncture site through the needle handle 1.

[0043] Example 3

[0044] The difference between this embodiment and Embodiment 1 is that the needle core 2 and the needle body 3 are each provided with two different models:

[0045] Needle core 2 is divided into needle core I and needle core II; the outer diameter of needle core I is 0.8mm, and the length of needle core I extending out of needle handle 1 is 4cm; the outer diameter of needle core II is 1.0mm, and the length of needle core II extending out of needle handle 1 is 6cm.

[0046] The needle body is divided into needle body I and needle body II; the inner diameter of needle body I is 0.8mm and the length is 4cm; the inner diameter of needle body II is 1.0mm and the length is 6cm.

[0047] The choice can be made according to the patient's specific condition: Needle core No. I can be used in combination with needle body No. I, or needle core No. II can be used in combination with needle body No. II.

[0048] Example 4

[0049] The difference between this embodiment and Embodiment 1 is that, in order to make the connecting tube 4 tightly connected to the needle handle 1 and the rubber stopper respectively, and to improve the sealing performance of the connection between the connecting tube 4 and the needle handle 1 and the rubber stopper respectively, a number of sealing rings are fixedly connected to the inner wall of the connecting tube 4. The sealing rings are detachably connected to the limiting grooves. The sealing rings are respectively opened on the needle handle 1 and the rubber stopper. The sealing rings are adapted to the limiting grooves. When the needle handle 1 and the rubber stopper are inserted into the connecting tube 4, the sealing rings are in the limiting grooves. The sealing rings are tightly locked in the limiting grooves, which effectively improves the sealing performance of the connection between the connecting tube 4 and the needle handle 1 or the rubber stopper.

[0050] This invention effectively performs fascial release, drug injection, and needle placement. By placing the needle 3 within the subcutaneous fascia, it stimulates both the fascia and acupoints, achieving the therapeutic effects of existing thread embedding and floating needle techniques. It also enables the needle 3 to serve multiple purposes, reducing the need for multiple punctures of the subcutaneous fascia and minimizing damage to blood vessels and nerves. Furthermore, it significantly reduces patient discomfort from repeated punctures and increases treatment safety. Moreover, by reducing the number of subcutaneous fascial punctures and the amount of consumables used, it effectively reduces patient medical expenses.

[0051] In the description of this utility model, it should be understood that the terms "longitudinal", "lateral", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings. They are only for the convenience of describing this utility model and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on this utility model.

[0052] The embodiments described above are merely preferred embodiments of the present utility model and are not intended to limit the scope of the present utility model. Various modifications and improvements made to the technical solutions of the present utility model by those skilled in the art without departing from the spirit of the present utility model should fall within the protection scope defined by the claims of the present utility model.

Claims

1. A disposable myofascial release implantation needle, characterized in that: It includes a delivery section detachably connected to a syringe, wherein an end of the delivery section away from the syringe is detachably connected to an embedding section for embedding in the fascia; The delivery unit includes a needle handle (1), and a needle core (2) is fixedly connected inside the needle handle (1); The implantation part includes a connecting tube (4), the end of the needle handle (1) away from the syringe is detachably connected to the connecting tube (4), the end of the connecting tube (4) away from the needle handle (1) is fixedly connected to and communicates with the needle body (3), and the needle body (3) has symmetrical injection holes (6) on the outer wall of the end away from the connecting tube (4). One end of the needle core (2) that extends into the needle handle (1) is connected to the syringe through the needle handle (1); the other end of the needle core (2) that extends out of the needle handle (1) passes through the connecting tube (4) and extends into the needle body (3).

2. The disposable myofascial release implantation needle according to claim 1, characterized in that: The needle handle (1) has an interface (7) at one end facing the syringe, and the interface (7) is detachably connected to the syringe.

3. The disposable myofascial release implantation needle according to claim 2, characterized in that: The interface (7) is cone-shaped, and the smaller end of the interface (7) is connected to the needle core (2).

4. The disposable myofascial release implantation needle according to claim 1, characterized in that: The end of the needle body (3) away from the connecting tube (4) is a blunt end (5).

5. The disposable myofascial release implantation needle according to claim 1, characterized in that: The needle tip of the needle core (2) inserted into the needle body (3) is a transverse cut.

6. The disposable myofascial release implantation needle according to claim 1, characterized in that: The length of the needle core (2) extending beyond the needle handle (1) is not greater than the length of the needle body (3).

7. The disposable myofascial release implantation needle according to claim 1, characterized in that: The end of the needle handle (1) facing the connecting tube (4) is conical.

8. The disposable myofascial release implantation needle according to claim 1, characterized in that: The needle body (3) and the connecting tube (4) are integrally formed.

9. The disposable myofascial release implantation needle according to claim 1, characterized in that: The needle body (3) and the connecting tube (4) are made of plastic.

Images